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Published by Elsevier Inc.CORRESPONDENCELetters to the EditorSafety of Same-Day Discharge
After Percutaneous Coronary
Intervention
What Is the Level of Evidence?We read with great interest the paper by Brayton et al. (1). This
paper is nearly identical to our recent publication in JACC:
Cardiovascular Interventions (2). It is interesting that 2 similar
papers using the same data would be published in the JACC family
of journals just a few months apart. Although Brayton and col-
leagues brieﬂy acknowledge our paper in their discussion section,
there are several aspects of their paper and claims regarding our
study that deserve comment.
1. Table 1 in the paper by Brayton et al. lists a study by Chung
et al. (3) as a randomized trial. We ask that they carefully
review this study again because it is clearly stated in the
paper that it is a prospective, nonrandomized study. We
included this study in our meta-analysis appropriately as an
observational study (reference 15).
2. Brayton and colleagues claim that their study differs from
ours partly because they included 1 randomized trial that we
did not. It appears that they are referring to a study by Glaser
et al. (4) that randomized 39 patients. We concede that this
was an oversight on our part, but given that we examined
data from >111,000 patients, its inclusion would not have
affected our results.
3. They also claim that they included 23 observational
studies that we did not. We rejected these from our
analysis because none of these studies included a com-
parator group who stayed overnight after a percutaneous
coronary intervention. Including these studies does not
conform to “best practice” for meta-analyses as described
by the MOOSE (Meta-analysis Of Observational Studies
in Epidemiology) group (5). Moreover, Brayton et al. (1)
only present the mean value of outcomes among patients
discharged the same day. No tables, forest plots, or
comparisons with overnight stay are presented. This, too,
violates meta-analytic best practice and cannot be used to
support the safety of same-day discharge.
4. We are concerned that Brayton and colleagues chose the
cumulative incidence of “death, MI, and TLR” as primary
outcomes in their meta-analysis as target lesion revascu-
larization was not reported in many of the included
studies. Most studies reported “repeat PCI or revascular-
ization,” which appears more clinically and cost relevant.
5. Although Brayton et al. (1) come to similar conclusions as
we did, we believe that they have overstated their ﬁndings.
Our conclusions were appropriately cautious considering thelarge heterogeneity of data and deﬁnitions used. This latter
point is not discussed by Brayton et al. (1) at all. We also
repeated our analysis using Bayesian techniques (data not
shown), and the available evidence is practically inconclusive
given the wide credible conﬁdence intervals around the point
estimates for outcomes. In contrast, Brayton et al. (1)
conclude that same-day discharge is “as safe” as overnight
observation. Although we agree with this on clinical grounds
in selected patients, it is a clear overstatement of the data on
statistical grounds.
6. On their last page of discussion, they claim that their study
has a “signiﬁcant methodological difference from [our
study], which included patients not discharged as a post hoc
‘control arm’.” It is not at all clear what this means because,
by deﬁnition, all analyses of observational data are necessarily
post hoc.*Olivier F. Bertrand, MD, PhD
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283:2008–12.ReplySafety of Same-Day Discharge After
Percutaneous Coronary Intervention
What Is the Level of Evidence?
In their letter, although Dr. Bertrand and colleagues raise a number
of points, their key concern appears to relate to the publication of 2
similar papers a few months apart. Our group was completely
unaware of the meta-analysis by Abdelaal et al. (1) until our paper
was already in revision at JACC, at which point we added a brief
discussion of their paper to our revised paper (2). We fully
acknowledge that the 2 papers are similar in content and conclu-
sions and ﬁnd it reassuring that 2 different groups working entirely
independently, and with some differences in methodology, reached
very similar conclusions. We believe that replication and validation
remain essential steps in the scientiﬁc process, particularly for
studies such as these that have direct clinical implications.
To speciﬁcally address the ﬁrst of the numbered critiques in
their letter, the paper by Chung et al. (3) clearly states in its
Methods section that: “Patients who had fulﬁlled the enrollment
criteria were randomly allocated to one of two groups: group A
(same-day discharge) and group B (routine admission for close
observation).” We acknowledge that the presentation of study
results in the Chung et al. (3) paper is contradictory to this
statement, however.
With regard to the issue of which observational studies were
included in the 2 meta-analyses (point 3), our approach to the
observational studies was markedly different from that of Abdelaal
et al. (1) which led to different criteria for study selection. Because
of our concerns about the validity of comparisons of non-
randomized study groups, we did not report any comparisons of
outcomes between same-day discharge and overnight observationin the observational studies, but rather used the observational
studies only to report pooled “real-world” absolute event rates
among those actually discharged on the day of the percutaneous
coronary intervention. This strategy avoids the substantial methodo-
logical weakness of observational comparisons but does allow the
observational data to be used to estimate aggregate event rates. We
continue to maintain that this is a methodological strength of our
paper relative to that of Abdelaal et al. (1)
Finally, we agree with Dr. Bertrand and colleagues that it would
be an overstatement to say, on the basis of either of our studies, that
same-day discharge is “as safe” as overnight observation. Rather, as
we stated in our original conclusions, larger, randomized studies of
same-day discharge are needed to deﬁnitively establish its safety
compared with overnight observation. In the meantime, the
aggregate data from both meta-analyses support consideration of
the practice in carefully selected patients.*Kimberly M. Brayton, MD, JD
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James A. De Lemos, MD
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